Altus Drug Development designs, develops and delivers Value-Added Medicines. We rethink and reinvent existing drugs, unlocking value for patients, providers and payers.
Because we develop our own Value-Added Medicines for outlicensing, we have the knowledge, experience and technology to develop yours.
Product Design and Development
Patented Technologies for Added Value
Altus Patent Umbrella
Lab to Clinic to Market
Integrated Drug Development Services
Preclinical Testing and Lead Selection
First in Human (FIH) Studies
Launch & Commercial Supplies
The Advantages of Value-Added Medicines
Altus Value-Added Medicines bring commercially and clinically meaningful benefits to new molecules (NCE or NME) and old, generating new labelling to avoid substitution while addressing the needs of patients, healthcare professionals and payers. Altus Value-Added Medicines allow premium pricing.
Let Us Help You